Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s10072-021-05180-8 http://scihub22266oqcxt.onion/10.1007/s10072-021-05180-8 33768436!7994064!33768436     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Neurol+Sci 2021 ; 42 (12): 5087-5092 Nephropedia Template TP {{tp|p=33768436|t=2021. Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown |pdf=|usr=}}{{33768436}} gab.com Text Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown JO: Neurol Sci http://www.kidney.de/pget.php?&tw=1&pmid=33768436 #FOAvip BACKGROUND: Face-to-face procedures have been postponed during COVID-19 pandemic. We aim to evaluate the impact of onabotulinumtoxinA follow-up delay in migraine during COVID-19 pandemic. METHODS: Subjective worsening, intensity of migraine attacks, and frequency of headache and migraine were retrospectively compared between patients with unmodified and interrupted onabotulinumtoxinA follow-up in Headache Units. RESULTS: We included 67 patients with chronic migraine or high-frequency episodic migraine under onabotulinumtoxinA treatment, 65 (97.0%) female, 44.5 +/- 12.1 years old. Treatment administration was voluntarily delayed in 14 (20.9%) patients and nine (13.4%) were unable to continue follow-up. Patients with uninterrupted follow-up during lockdown presented 7.6 and 8.1 less monthly days with headache (adjusted p = 0.017) and migraine attacks (adjusted p = 0.009) compared to patients whose follow-up was interrupted, respectively. CONCLUSION: Involuntary delay of onabotulinumtoxinA follow-up in patients with migraine due to COVID-19 pandemic was associated with a higher frequency of headache and migraine attacks. Safe administration of onabotulinumtoxinA during lockdown should be promoted. Twit Text FOAVip Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown ????Neurol Sci http://www.kidney.de/pget.php?&tw=1&pmid=33768436 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33768436 #FOAvip English Wikipedia <ref>{{Cite pmid|33768436}}</ref> Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown #MMPMID33768436 Gonzalez-Martinez A; Planchuelo-Gomez A; Guerrero AL; Garcia-Azorin D; Santos-Lasaosa S; Navarro-Perez MP; Odriozola-Gonzalez P; Irurtia MJ; Quintas S; de Luis-Garcia R; Gago-Veiga AB Neurol Sci 2021[Dec]; 42 (12): 5087-5092 PMID33768436show ga BACKGROUND: Face-to-face procedures have been postponed during COVID-19 pandemic. We aim to evaluate the impact of onabotulinumtoxinA follow-up delay in migraine during COVID-19 pandemic. METHODS: Subjective worsening, intensity of migraine attacks, and frequency of headache and migraine were retrospectively compared between patients with unmodified and interrupted onabotulinumtoxinA follow-up in Headache Units. RESULTS: We included 67 patients with chronic migraine or high-frequency episodic migraine under onabotulinumtoxinA treatment, 65 (97.0%) female, 44.5 +/- 12.1 years old. Treatment administration was voluntarily delayed in 14 (20.9%) patients and nine (13.4%) were unable to continue follow-up. Patients with uninterrupted follow-up during lockdown presented 7.6 and 8.1 less monthly days with headache (adjusted p = 0.017) and migraine attacks (adjusted p = 0.009) compared to patients whose follow-up was interrupted, respectively. CONCLUSION: Involuntary delay of onabotulinumtoxinA follow-up in patients with migraine due to COVID-19 pandemic was associated with a higher frequency of headache and migraine attacks. Safe administration of onabotulinumtoxinA during lockdown should be promoted. |*Botulinum Toxins, Type A[MESH] |*COVID-19[MESH] |*Migraine Disorders/drug therapy/epidemiology[MESH] |Adult[MESH] |Chronic Disease[MESH] |Communicable Disease Control[MESH] |Female[MESH] |Follow-Up Studies[MESH] |Humans[MESH] |Middle Aged[MESH] |Pandemics[MESH] |Retrospective Studies[MESH] |SARS-CoV-2[MESH]Effects of the onabotulinumtoxinA follow-up delay in migraine course d(epmc).pdf DeepDyve Pubget Overpricing